Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity
Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical rol...
Gespeichert in:
Veröffentlicht in: | Acta pharmacologica Sinica 2013-04, Vol.34 (4), p.522-530 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 530 |
---|---|
container_issue | 4 |
container_start_page | 522 |
container_title | Acta pharmacologica Sinica |
container_volume | 34 |
creator | Wan, Chun-ping Gao, Li-xin Hou, Li-fei Yang, Xiao-qian He, Pei-lan Yang, Yi-fu Tang, Wei Yue, Jian-min Li, Jia Zuo, Jian-ping |
description | Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical role in T lymphocyte activation. Methods: Primary splenocytes and T cells were prepared from mice. CD45 PTPase activity was assessed using a colorimetric assay. Cell proliferation was measured using a [3H]-thymidine incorporation assay. Cytokine proteins and mRNAs were examined with ELISA and RT-PCR, respectively. Activation markers, including CD25 and CD69, were analyzed using flow cytometry. Activation of LCK (Tyr505) was detected using Western blot analysis. Mice were injected with the immunosuppressant cyclophosphamide (CTX, 80 mg/kg), and administered astragaloside II (50 mg/kg). Results: Astragaloside I, II, III, and IV concentration-dependently increased the CD45-mediated of pNPP/OMFP hydrolysis with the ECso values ranged from 3.33 to 10.42 pg/mL. Astragaloside II (10 and 30 IJg/mL) significantly enhanced the proliferation of primary splenocytes induced by ConA, alloantigen or anti-CD3. Astragaloside II (30 pg/mL) significantly increased IL-2 and IFN-y secretion, upregulated the mRNA levels of IFN-~ and T-bet in primary splenocytes, and promoted CD25 and CD69 expression on primary CD4~ T cells upon TCR stimulation. Furthermore, astragaloside II (100 ng/mL) promoted CD45-mediated dephosphorylation of LCK (Tyr505) in primary T cells, which could be blocked by a specific CD45 PTPase inhibitor. In CTX-induced immunosuppressed mice, oral administration of astragaloside II restored the proliferation of splenic T cells and the production of IFN-γ and IL-2. However, astragaloside II had no apparent effects on B cell proliferation. Conclusion: Astragaloside II enhances T cell activation by regulating the activity of CD45 PTPase, which may explain why Astragalus membranaceus Bge is used as a tonic herb in treating immunosuppressive diseases. |
doi_str_mv | 10.1038/aps.2012.208 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4002795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>45518997</cqvip_id><sourcerecordid>1324390472</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-1ad7a0e16de90f72438449e8076fe988b48a297f3ee40bb6a49a6f9d60338ef63</originalsourceid><addsrcrecordid>eNptkctv1DAQxiMEog-4cUZGXDiQ4ldi-1KpWgqsVIlLOVve7CRxlY1T26m0_z2zyrIqiMvY8vz8zeMrineMXjEq9Bc3pStOGcegXxTnTMmqVLySL_FeK1ZKqsVZcZHSA6WCC2ZeF2dcVFxWSpwXw03K0XVuCMlvgazXJEffdRATuScNDANxTfZPLvswktzHMHc9idDNw_IUWrL6KisyxZDBI7KPqDQCmfqQpt5ll2CR8Hn_pnjVuiHB2-N5Wfz6dnu_-lHe_fy-Xt3clY1UdS6Z2ypHgdVbMLRVXAotpQFNVd2C0XojteNGtQJA0s2mdtK4ujXbmgqhoa3FZXG96E7zZgfbBkaccbBT9DsX9zY4b__OjL63XXiyklKuTIUCn44CMTzOkLLd-XTYhhshzMkygU0ZKhVH9OM_6EOY44jjHSihlcCVI_V5oRpcT4rQnpph1B5stGijPdiIQSP-_vkAJ_iPbwiUC5AwNaJdz6r-X_DDsX4fxu4Rv5w0ZVUxbYwSvwH047Ru</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1323873319</pqid></control><display><type>article</type><title>Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Wan, Chun-ping ; Gao, Li-xin ; Hou, Li-fei ; Yang, Xiao-qian ; He, Pei-lan ; Yang, Yi-fu ; Tang, Wei ; Yue, Jian-min ; Li, Jia ; Zuo, Jian-ping</creator><creatorcontrib>Wan, Chun-ping ; Gao, Li-xin ; Hou, Li-fei ; Yang, Xiao-qian ; He, Pei-lan ; Yang, Yi-fu ; Tang, Wei ; Yue, Jian-min ; Li, Jia ; Zuo, Jian-ping</creatorcontrib><description>Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical role in T lymphocyte activation. Methods: Primary splenocytes and T cells were prepared from mice. CD45 PTPase activity was assessed using a colorimetric assay. Cell proliferation was measured using a [3H]-thymidine incorporation assay. Cytokine proteins and mRNAs were examined with ELISA and RT-PCR, respectively. Activation markers, including CD25 and CD69, were analyzed using flow cytometry. Activation of LCK (Tyr505) was detected using Western blot analysis. Mice were injected with the immunosuppressant cyclophosphamide (CTX, 80 mg/kg), and administered astragaloside II (50 mg/kg). Results: Astragaloside I, II, III, and IV concentration-dependently increased the CD45-mediated of pNPP/OMFP hydrolysis with the ECso values ranged from 3.33 to 10.42 pg/mL. Astragaloside II (10 and 30 IJg/mL) significantly enhanced the proliferation of primary splenocytes induced by ConA, alloantigen or anti-CD3. Astragaloside II (30 pg/mL) significantly increased IL-2 and IFN-y secretion, upregulated the mRNA levels of IFN-~ and T-bet in primary splenocytes, and promoted CD25 and CD69 expression on primary CD4~ T cells upon TCR stimulation. Furthermore, astragaloside II (100 ng/mL) promoted CD45-mediated dephosphorylation of LCK (Tyr505) in primary T cells, which could be blocked by a specific CD45 PTPase inhibitor. In CTX-induced immunosuppressed mice, oral administration of astragaloside II restored the proliferation of splenic T cells and the production of IFN-γ and IL-2. However, astragaloside II had no apparent effects on B cell proliferation. Conclusion: Astragaloside II enhances T cell activation by regulating the activity of CD45 PTPase, which may explain why Astragalus membranaceus Bge is used as a tonic herb in treating immunosuppressive diseases.</description><identifier>ISSN: 1671-4083</identifier><identifier>EISSN: 1745-7254</identifier><identifier>DOI: 10.1038/aps.2012.208</identifier><identifier>PMID: 23524573</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Animals ; Astragalus membranaceus - chemistry ; Astragalus membranaceus - immunology ; Biomedical and Life Sciences ; Biomedicine ; CD3 Complex - genetics ; CD3 Complex - immunology ; CD3 Complex - metabolism ; CD4-Positive T-Lymphocytes - drug effects ; CD4-Positive T-Lymphocytes - immunology ; CD4-Positive T-Lymphocytes - metabolism ; Female ; Immunology ; Interferon-gamma - genetics ; Interferon-gamma - immunology ; Interferon-gamma - metabolism ; Interleukin-2 - immunology ; Interleukin-2 - metabolism ; Internal Medicine ; Leukocyte Common Antigens - immunology ; Leukocyte Common Antigens - metabolism ; Lymphocyte Activation - drug effects ; Medical Microbiology ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; mRNA水平 ; Original ; original-article ; Pharmacology/Toxicology ; Protein Tyrosine Phosphatases - immunology ; Protein Tyrosine Phosphatases - metabolism ; Random Allocation ; Saponins - immunology ; Saponins - pharmacology ; T-Lymphocytes - drug effects ; T-Lymphocytes - immunology ; T-Lymphocytes - metabolism ; Tyrosine - immunology ; Tyrosine - metabolism ; T细胞活化 ; Vaccine ; 免疫抑制剂 ; 免疫调节活性 ; 比色法测定 ; 脾细胞增殖 ; 蛋白酪氨酸磷酸酶 ; 黄芪皂苷</subject><ispartof>Acta pharmacologica Sinica, 2013-04, Vol.34 (4), p.522-530</ispartof><rights>CPS and SIMM 2013</rights><rights>Copyright Nature Publishing Group Apr 2013</rights><rights>Copyright © 2013 CPS and SIMM 2013 CPS and SIMM</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-1ad7a0e16de90f72438449e8076fe988b48a297f3ee40bb6a49a6f9d60338ef63</citedby><cites>FETCH-LOGICAL-c476t-1ad7a0e16de90f72438449e8076fe988b48a297f3ee40bb6a49a6f9d60338ef63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/95561A/95561A.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002795/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002795/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23524573$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wan, Chun-ping</creatorcontrib><creatorcontrib>Gao, Li-xin</creatorcontrib><creatorcontrib>Hou, Li-fei</creatorcontrib><creatorcontrib>Yang, Xiao-qian</creatorcontrib><creatorcontrib>He, Pei-lan</creatorcontrib><creatorcontrib>Yang, Yi-fu</creatorcontrib><creatorcontrib>Tang, Wei</creatorcontrib><creatorcontrib>Yue, Jian-min</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><creatorcontrib>Zuo, Jian-ping</creatorcontrib><title>Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity</title><title>Acta pharmacologica Sinica</title><addtitle>Acta Pharmacol Sin</addtitle><addtitle>Acta Pharmacologica Sinica</addtitle><description>Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical role in T lymphocyte activation. Methods: Primary splenocytes and T cells were prepared from mice. CD45 PTPase activity was assessed using a colorimetric assay. Cell proliferation was measured using a [3H]-thymidine incorporation assay. Cytokine proteins and mRNAs were examined with ELISA and RT-PCR, respectively. Activation markers, including CD25 and CD69, were analyzed using flow cytometry. Activation of LCK (Tyr505) was detected using Western blot analysis. Mice were injected with the immunosuppressant cyclophosphamide (CTX, 80 mg/kg), and administered astragaloside II (50 mg/kg). Results: Astragaloside I, II, III, and IV concentration-dependently increased the CD45-mediated of pNPP/OMFP hydrolysis with the ECso values ranged from 3.33 to 10.42 pg/mL. Astragaloside II (10 and 30 IJg/mL) significantly enhanced the proliferation of primary splenocytes induced by ConA, alloantigen or anti-CD3. Astragaloside II (30 pg/mL) significantly increased IL-2 and IFN-y secretion, upregulated the mRNA levels of IFN-~ and T-bet in primary splenocytes, and promoted CD25 and CD69 expression on primary CD4~ T cells upon TCR stimulation. Furthermore, astragaloside II (100 ng/mL) promoted CD45-mediated dephosphorylation of LCK (Tyr505) in primary T cells, which could be blocked by a specific CD45 PTPase inhibitor. In CTX-induced immunosuppressed mice, oral administration of astragaloside II restored the proliferation of splenic T cells and the production of IFN-γ and IL-2. However, astragaloside II had no apparent effects on B cell proliferation. Conclusion: Astragaloside II enhances T cell activation by regulating the activity of CD45 PTPase, which may explain why Astragalus membranaceus Bge is used as a tonic herb in treating immunosuppressive diseases.</description><subject>Animals</subject><subject>Astragalus membranaceus - chemistry</subject><subject>Astragalus membranaceus - immunology</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>CD3 Complex - genetics</subject><subject>CD3 Complex - immunology</subject><subject>CD3 Complex - metabolism</subject><subject>CD4-Positive T-Lymphocytes - drug effects</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD4-Positive T-Lymphocytes - metabolism</subject><subject>Female</subject><subject>Immunology</subject><subject>Interferon-gamma - genetics</subject><subject>Interferon-gamma - immunology</subject><subject>Interferon-gamma - metabolism</subject><subject>Interleukin-2 - immunology</subject><subject>Interleukin-2 - metabolism</subject><subject>Internal Medicine</subject><subject>Leukocyte Common Antigens - immunology</subject><subject>Leukocyte Common Antigens - metabolism</subject><subject>Lymphocyte Activation - drug effects</subject><subject>Medical Microbiology</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>mRNA水平</subject><subject>Original</subject><subject>original-article</subject><subject>Pharmacology/Toxicology</subject><subject>Protein Tyrosine Phosphatases - immunology</subject><subject>Protein Tyrosine Phosphatases - metabolism</subject><subject>Random Allocation</subject><subject>Saponins - immunology</subject><subject>Saponins - pharmacology</subject><subject>T-Lymphocytes - drug effects</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - metabolism</subject><subject>Tyrosine - immunology</subject><subject>Tyrosine - metabolism</subject><subject>T细胞活化</subject><subject>Vaccine</subject><subject>免疫抑制剂</subject><subject>免疫调节活性</subject><subject>比色法测定</subject><subject>脾细胞增殖</subject><subject>蛋白酪氨酸磷酸酶</subject><subject>黄芪皂苷</subject><issn>1671-4083</issn><issn>1745-7254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkctv1DAQxiMEog-4cUZGXDiQ4ldi-1KpWgqsVIlLOVve7CRxlY1T26m0_z2zyrIqiMvY8vz8zeMrineMXjEq9Bc3pStOGcegXxTnTMmqVLySL_FeK1ZKqsVZcZHSA6WCC2ZeF2dcVFxWSpwXw03K0XVuCMlvgazXJEffdRATuScNDANxTfZPLvswktzHMHc9idDNw_IUWrL6KisyxZDBI7KPqDQCmfqQpt5ll2CR8Hn_pnjVuiHB2-N5Wfz6dnu_-lHe_fy-Xt3clY1UdS6Z2ypHgdVbMLRVXAotpQFNVd2C0XojteNGtQJA0s2mdtK4ujXbmgqhoa3FZXG96E7zZgfbBkaccbBT9DsX9zY4b__OjL63XXiyklKuTIUCn44CMTzOkLLd-XTYhhshzMkygU0ZKhVH9OM_6EOY44jjHSihlcCVI_V5oRpcT4rQnpph1B5stGijPdiIQSP-_vkAJ_iPbwiUC5AwNaJdz6r-X_DDsX4fxu4Rv5w0ZVUxbYwSvwH047Ru</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Wan, Chun-ping</creator><creator>Gao, Li-xin</creator><creator>Hou, Li-fei</creator><creator>Yang, Xiao-qian</creator><creator>He, Pei-lan</creator><creator>Yang, Yi-fu</creator><creator>Tang, Wei</creator><creator>Yue, Jian-min</creator><creator>Li, Jia</creator><creator>Zuo, Jian-ping</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130401</creationdate><title>Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity</title><author>Wan, Chun-ping ; Gao, Li-xin ; Hou, Li-fei ; Yang, Xiao-qian ; He, Pei-lan ; Yang, Yi-fu ; Tang, Wei ; Yue, Jian-min ; Li, Jia ; Zuo, Jian-ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-1ad7a0e16de90f72438449e8076fe988b48a297f3ee40bb6a49a6f9d60338ef63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Astragalus membranaceus - chemistry</topic><topic>Astragalus membranaceus - immunology</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>CD3 Complex - genetics</topic><topic>CD3 Complex - immunology</topic><topic>CD3 Complex - metabolism</topic><topic>CD4-Positive T-Lymphocytes - drug effects</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD4-Positive T-Lymphocytes - metabolism</topic><topic>Female</topic><topic>Immunology</topic><topic>Interferon-gamma - genetics</topic><topic>Interferon-gamma - immunology</topic><topic>Interferon-gamma - metabolism</topic><topic>Interleukin-2 - immunology</topic><topic>Interleukin-2 - metabolism</topic><topic>Internal Medicine</topic><topic>Leukocyte Common Antigens - immunology</topic><topic>Leukocyte Common Antigens - metabolism</topic><topic>Lymphocyte Activation - drug effects</topic><topic>Medical Microbiology</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>mRNA水平</topic><topic>Original</topic><topic>original-article</topic><topic>Pharmacology/Toxicology</topic><topic>Protein Tyrosine Phosphatases - immunology</topic><topic>Protein Tyrosine Phosphatases - metabolism</topic><topic>Random Allocation</topic><topic>Saponins - immunology</topic><topic>Saponins - pharmacology</topic><topic>T-Lymphocytes - drug effects</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - metabolism</topic><topic>Tyrosine - immunology</topic><topic>Tyrosine - metabolism</topic><topic>T细胞活化</topic><topic>Vaccine</topic><topic>免疫抑制剂</topic><topic>免疫调节活性</topic><topic>比色法测定</topic><topic>脾细胞增殖</topic><topic>蛋白酪氨酸磷酸酶</topic><topic>黄芪皂苷</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wan, Chun-ping</creatorcontrib><creatorcontrib>Gao, Li-xin</creatorcontrib><creatorcontrib>Hou, Li-fei</creatorcontrib><creatorcontrib>Yang, Xiao-qian</creatorcontrib><creatorcontrib>He, Pei-lan</creatorcontrib><creatorcontrib>Yang, Yi-fu</creatorcontrib><creatorcontrib>Tang, Wei</creatorcontrib><creatorcontrib>Yue, Jian-min</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><creatorcontrib>Zuo, Jian-ping</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta pharmacologica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wan, Chun-ping</au><au>Gao, Li-xin</au><au>Hou, Li-fei</au><au>Yang, Xiao-qian</au><au>He, Pei-lan</au><au>Yang, Yi-fu</au><au>Tang, Wei</au><au>Yue, Jian-min</au><au>Li, Jia</au><au>Zuo, Jian-ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity</atitle><jtitle>Acta pharmacologica Sinica</jtitle><stitle>Acta Pharmacol Sin</stitle><addtitle>Acta Pharmacologica Sinica</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>34</volume><issue>4</issue><spage>522</spage><epage>530</epage><pages>522-530</pages><issn>1671-4083</issn><eissn>1745-7254</eissn><abstract>Aim: To investigate the immunomodulating activity of astragalosides, the active compounds from a traditional tonic herb Astragalus membranaceus Bge, and to explore the molecular mechanisms underlying the actions, focusing on CD45 protein tyrosine phosphatase (CD45 PTPase), which plays a critical role in T lymphocyte activation. Methods: Primary splenocytes and T cells were prepared from mice. CD45 PTPase activity was assessed using a colorimetric assay. Cell proliferation was measured using a [3H]-thymidine incorporation assay. Cytokine proteins and mRNAs were examined with ELISA and RT-PCR, respectively. Activation markers, including CD25 and CD69, were analyzed using flow cytometry. Activation of LCK (Tyr505) was detected using Western blot analysis. Mice were injected with the immunosuppressant cyclophosphamide (CTX, 80 mg/kg), and administered astragaloside II (50 mg/kg). Results: Astragaloside I, II, III, and IV concentration-dependently increased the CD45-mediated of pNPP/OMFP hydrolysis with the ECso values ranged from 3.33 to 10.42 pg/mL. Astragaloside II (10 and 30 IJg/mL) significantly enhanced the proliferation of primary splenocytes induced by ConA, alloantigen or anti-CD3. Astragaloside II (30 pg/mL) significantly increased IL-2 and IFN-y secretion, upregulated the mRNA levels of IFN-~ and T-bet in primary splenocytes, and promoted CD25 and CD69 expression on primary CD4~ T cells upon TCR stimulation. Furthermore, astragaloside II (100 ng/mL) promoted CD45-mediated dephosphorylation of LCK (Tyr505) in primary T cells, which could be blocked by a specific CD45 PTPase inhibitor. In CTX-induced immunosuppressed mice, oral administration of astragaloside II restored the proliferation of splenic T cells and the production of IFN-γ and IL-2. However, astragaloside II had no apparent effects on B cell proliferation. Conclusion: Astragaloside II enhances T cell activation by regulating the activity of CD45 PTPase, which may explain why Astragalus membranaceus Bge is used as a tonic herb in treating immunosuppressive diseases.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>23524573</pmid><doi>10.1038/aps.2012.208</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1671-4083 |
ispartof | Acta pharmacologica Sinica, 2013-04, Vol.34 (4), p.522-530 |
issn | 1671-4083 1745-7254 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4002795 |
source | MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | Animals Astragalus membranaceus - chemistry Astragalus membranaceus - immunology Biomedical and Life Sciences Biomedicine CD3 Complex - genetics CD3 Complex - immunology CD3 Complex - metabolism CD4-Positive T-Lymphocytes - drug effects CD4-Positive T-Lymphocytes - immunology CD4-Positive T-Lymphocytes - metabolism Female Immunology Interferon-gamma - genetics Interferon-gamma - immunology Interferon-gamma - metabolism Interleukin-2 - immunology Interleukin-2 - metabolism Internal Medicine Leukocyte Common Antigens - immunology Leukocyte Common Antigens - metabolism Lymphocyte Activation - drug effects Medical Microbiology Mice Mice, Inbred BALB C Mice, Inbred C57BL mRNA水平 Original original-article Pharmacology/Toxicology Protein Tyrosine Phosphatases - immunology Protein Tyrosine Phosphatases - metabolism Random Allocation Saponins - immunology Saponins - pharmacology T-Lymphocytes - drug effects T-Lymphocytes - immunology T-Lymphocytes - metabolism Tyrosine - immunology Tyrosine - metabolism T细胞活化 Vaccine 免疫抑制剂 免疫调节活性 比色法测定 脾细胞增殖 蛋白酪氨酸磷酸酶 黄芪皂苷 |
title | Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T18%3A58%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Astragaloside%20II%20triggers%20T%20cell%20activation%20through%20regulation%20of%20CD45%20protein%20tyrosine%20phosphatase%20activity&rft.jtitle=Acta%20pharmacologica%20Sinica&rft.au=Wan,%20Chun-ping&rft.date=2013-04-01&rft.volume=34&rft.issue=4&rft.spage=522&rft.epage=530&rft.pages=522-530&rft.issn=1671-4083&rft.eissn=1745-7254&rft_id=info:doi/10.1038/aps.2012.208&rft_dat=%3Cproquest_pubme%3E1324390472%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1323873319&rft_id=info:pmid/23524573&rft_cqvip_id=45518997&rfr_iscdi=true |